December 26, 2023 — Results published in the American Journal of Roentgenology (AJR) support mammographic surveillance protocol for patients with a previous breast cancer diagnosis of returning immediately to digital breast tomosynthesis (DBT) screening. “Although the abnormal interpretation rate (AIR) was higher during the year after diagnosis compared to subsequent years, the AIR remained acceptably low (< 10%) in...
December 26, 2023 — Kansas City Proton Institute (KCPI), the first physician-led proton therapy center in the Midwest, and Mevion Medical Systems announced today that the first four patients were treated at Kansas City Proton Institute on Dec. 19, with the MEVION S250i Proton Therapy System. Kansas City Proton Institute recently opened the doors to its new…
December 22, 2023 — Quibim, a company pioneering imaging biomarkers for Precision Medicine that has created AI-based software to identify early-stage neurodegenerative diseases, is pleased to announce today the launch of QP-Brain. This follows the product receiving an FDA 510(k) clearance from the US Food and Drug Administration, a CE mark for the European Union and…
December 22, 2023 — Volpara Health Technologies Ltd., a global leader in software for the early detection and prevention of cancer, was featured in two peer reviewed studies published during this year’s Radiological Society of North America (RSNA) annual meeting. Transforming the breast dose model The prestigious Joint AAPM Task Group 282/EFOMP Working Group, focused on modernizing breast radiation…
December 22, 2023 — Annual low-dose CT screening has been recently shown to result in high cure rates of over 80%, but methods of conducting a lung cancer screening program vary and best practices have yet to emerge. To address this, the International Association for the Study of Lung Cancer (IASLC) Early Detection and Screening Committee…
December 20, 2023 — An estimated 600,000 people in the United States succumb to cancer every year. Beyond surgery, chemotherapy, and immunotherapy, radiotherapy has shown to be a standard and effective treatment option for nearly 50-70 percent of cancer patients. Radiotherapy treatment involves six basic stages: initial consultation, simulation, treatment planning, treatment delivery, treatment verification and…
December 20, 2023 — Terran Biosciences, Inc., a biotech platform company developing therapeutics and technologies for patients with neuropsychiatric illnesses, has received FDA clearance to market NM-101, a cloud-based software platform to analyze neuromelanin-sensitive MRI scans. Currently, there is no other FDA-cleared software indicated for the analysis of neuromelanin MRI on the market, making Terran’s technology…